ctrl K

Rani Therapeutics Inc. (RANI)

NASDAQ: RANI · Real-Time Price · USD

1.09

0.02 (1.87%)

At close: May 02, 2025, 2:52 PM

Rani Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.03M	n/a	n/a	2.72M	462K	979K
Cost of Revenue	n/a	822K	1.31M	n/a	n/a	n/a
Gross Profit	1.03M	-822K	-1.31M	2.72M	462K	979K
Operating Income	-53.31M	-66.1M	-63.45M	-51.6M	-16.54M	-27.07M
Interest Income	1.76M	3.3M	1.25M	89K	63K	423K
Pretax Income	-30.02M	-67.88M	-63.27M	-53.05M	-16.67M	-26.59M
Net Income	-30.02M	-33.97M	-63.34M	-53.09M	-16.7M	-26.6M
Selling & General & Admin	23.95M	26.48M	26.84M	27.83M	4.96M	3.46M
Research & Development	26.68M	39.62M	36.61M	26.48M	12.04M	24.58M
Other Expenses	3.71M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	54.34M	66.1M	63.45M	54.32M	17.01M	28.04M
Interest Expense	5.03M	5.08M	1.07M	466K	124K	10K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	54.34M	66.1M	63.45M	54.32M	17.01M	28.04M
Income Tax Expense	26.57M	n/a	70K	41K	35K	10K
Shares Outstanding (Basic)	28.48M	25.5M	23.82M	19.71M	19.74M	19.74M
Shares Outstanding (Diluted)	28.48M	25.5M	23.82M	19.71M	19.74M	19.74M
EPS (Basic)	-1.05	-1.33	-2.66	-2.69	-0.85	-1.35
EPS (Diluted)	-1.05	-1.33	-2.66	-2.69	-0.85	-1.35
EBITDA	-50.52M	-65.28M	-60.89M	-52.08M	-15.96M	-26.01M
EBIT	-51.55M	-66.1M	-62.2M	-52.58M	-16.54M	-26.58M
Depreciation & Amortization	1.03M	822K	1.31M	497K	589K	564K